Xenon Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
XENE Nasdaq 2834 http://www.xenon-pharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Misses Revenue Estimates - May 10th, 2022 9:45 pm
Xenon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update - May 10th, 2022 8:01 pm
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Lags Revenue Estimates - May 9th, 2022 10:25 pm
Puma Biotech (PBYI) Reports Q1 Loss, Misses Revenue Estimates - May 5th, 2022 10:05 pm
G1 Therapeutics (GTHX) Reports Q1 Loss, Tops Revenue Estimates - May 4th, 2022 11:45 am
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Corporate Update - May 3rd, 2022 8:01 pm
Xenon Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial to Evaluate XEN1101 as a Treatment for Major Depressive Disorder (MDD) - May 3rd, 2022 12:00 pm
Xenon Pharmaceuticals Inc.'s (NASDAQ:XENE) Intrinsic Value Is Potentially 100% Above Its Share Price - Apr 29th, 2022 6:25 pm
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences - Apr 25th, 2022 8:01 pm
Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference - Apr 4th, 2022 8:01 pm
Xenon Pharmaceuticals to Present at Stifel 2022 CNS Days - Mar 22nd, 2022 8:01 pm
Xenon Pharmaceuticals (XENE) Reports Q4 Loss, Lags Revenue Estimates - Mar 1st, 2022 10:25 pm
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update - Mar 1st, 2022 9:01 pm
Tabula Rasa Healthcare (TRHC) Reports Q4 Loss, Tops Revenue Estimates - Feb 25th, 2022 1:10 am
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2021 Financial Results and Provide Corporate Update - Feb 22nd, 2022 9:01 pm
Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates - Feb 16th, 2022 1:15 pm
Xenon Pharmaceuticals to Participate in the 11th Annual SVB Leerink Global Healthcare Conference - Feb 14th, 2022 9:01 pm
How Did Hedge Funds’ Xenon Pharmaceuticals Inc (XENE) Bets Fare? - Feb 6th, 2022 9:40 pm
Accel Wealth Management Buys Vanguard Total Stock Market ETF, iShares Core Dividend Growth ETF, ... - Jan 18th, 2022 10:38 pm
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone - Jan 12th, 2022 1:00 pm